North Crest Asset Manangement, LLC Nuvasive Inc Transaction History

North Crest Asset Manangement, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	SELL	$36.71 - $44.15 $7,342 - $8,830	-200 Reduced 1.37%	14,380 $598,000
Q1 2023 Apr 25, 2023	BUY	$36.81 - $48.12 $25,767 - $33,684	700 Added 5.04%	14,580 $602,000
Q4 2022 Feb 01, 2023	BUY	$35.68 - $44.71 $9,990 - $12,518	280 Added 2.06%	13,880 $572,000
Q1 2022 Apr 18, 2022	BUY	$48.09 - $57.79 $387,124 - $465,209	8,050 Added 145.05%	13,600 $771,000
Q4 2021 Feb 09, 2022	BUY	$47.19 - $62.68 $261,904 - $347,874	5,550 New	5,550 $291,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

Stay updated on North Crest Asset Manangement, LLC with notifications on news.